Acadia Pharmaceuticals

Listing Websites about Acadia Pharmaceuticals

Filter Type:

Acadia Pharmaceuticals: Elevating Life Through Science

(9 days ago) WebEveryone at Acadia shares in our commitment to make a difference for our mothers and fathers. For our daughters and sons. For our grandparents, friends and …

Url: Visit Now

Category:  Health Detail Drugs


Acadia Pharmaceuticals - Wikipedia

(2 days ago) Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ACADIA Pharmaceuticals Inc. (ACAD) - Yahoo!

(6 days ago) WebFind the latest ACADIA Pharmaceuticals Inc. (ACAD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Acadia Pharmaceuticals Submits New Drug Application to the U.S.

(5 days ago) WebSAN DIEGO--(BUSINESS WIRE)--Jul. 18, 2022-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a New Drug …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ACAD Stock Price ACADIA Pharmaceuticals Inc. Stock Quote (U.S

(8 days ago) WebAcadia Pharmaceuticals stock price target cut to $25 from $37 at Mizuho. Apr. 6, 2021 at 6:42 a.m. ET by Tomi Kilgore.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ACADIA Pharmaceuticals - ACAD Stock Forecast, Price …

(6 days ago) WebWhat is ACADIA Pharmaceuticals' stock price forecast for 2023? 18 analysts have issued twelve-month price targets for ACADIA Pharmaceuticals' shares. Their ACAD share price forecasts range from …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Is Acadia Pharmaceuticals a Buy? The Motley Fool

(8 days ago) WebAcadia Pharmaceuticals's first-quarter sales were driven by strong execution in marketing and commercial strategy. The $90.1 million in revenue came from 32% …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Should You Buy ACADIA Pharmaceuticals Stock At $22? - Forbes

(8 days ago) WebWe believe that ACADIA Pharmaceuticals stock (NASDAQ NDAQ +2.3%: ACAD), a biopharmaceutical company focused on neuroscience drugs, is a good buying …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ACADIA Pharmaceuticals Company Profile - Craft

(9 days ago) WebACADIA Pharmaceuticals (formerly known as Receptor Technologies) is a biopharmaceutical company focused on the development and commercialization of …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Acadia Pharmaceuticals, Inc. Company Information - Drugs.com

(Just Now) WebAcadia Pharmaceuticals Submits NDA for Nuplazid for the Treatment of Parkinson’s Disease Psychosis 3 September 2015; Drugs Associated with Acadia …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


About - The Top Pharmaceutical Company in USA - Cipla

(3 days ago) WebFor more than 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 80+ countries. Our portfolio includes over …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Leading Pharmaceutical Company in USA Cipla USA Inc.

(5 days ago) WebCipla USA Inc. - One of the leading pharmaceutical companies in USA with over 1500 products with 60 plus dosage forms. US FDA approved since 1984.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Contact us — Acadia Home Health Care

(3 days ago) Web1861 Hooper Avenue Unit 2 Toms River, NJ 08753 (732) 255-7500. Monday – Friday: 9AM – 5PM Saturday-Sunday: Closed Essex, bergen, union, hudson and pasaic counties

Url: Visit Now

Category:  Health Detail Drugs

Popular Searched

 › How much is the deductible for medicare

 › Career development coordinator duties

 › Provider medicare number lookup

 › Medicare part d pdp definition

 › Arizona supplemental insurance for medicare

 › Alaska medical licensing board

 › Iu health plans in

 › Cms gov medicare provider portal

 › What does part b medicare cover

 › Cms center for medicare

Recently Searched

 › Abeka grade 9 health quiz 2

 › Tricare how to change plans

 › Newly approved drugs fda

 › All fda approved drugs

 › Fda approved chemotherapy drugs

 › Universities with pharmacy majors

 › Pa drug court association

 › Medical records documentation standards

 › A plus family health

 › Transition of care jobs

FAQ about Acadia Pharmaceuticals

Is Acadia a biopharmaceutical company?

San Diego, CA, U.S. Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in San Diego, California. On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

What is the target price for Acadia Pharmaceuticals (ACAD) stock?

17 analysts have issued 1-year target prices for ACADIA Pharmaceuticals' stock. Their ACAD share price forecasts range from $10.00 to $35.00. On average, they anticipate the company's share price to reach $20.35 in the next twelve months. This suggests a possible upside of 32.9% from the stock's current price.

What is Acadia?

For the millions of people impacted by neurological disorders and fighting for their future every day. We are Acadia – fiercely committed to our mission of elevating life through science. We fight disease so more you shines through. People living with neurological and mental health disorders have a light that deserves to be seen.

How did Acadia Pharmaceuticals perform in the first quarter?

In its first-quarter earnings report, released May 7, Acadia reported revenue of $90.1 million, a 43% increase year over year, and posted a net loss of $88 million, or $0.57 per share. Despite the challenges of the recent pandemic, investors liked what they heard from the recent earnings call. Here are the key takeaways for Acadia Pharmaceuticals.